Ben Seeliger

Respiratory Medicine Physician and Clinician Scientist at Hannover Medical School

[Ben Seeliger @BenSeeliger]

Great experience at #ERSCongress with cool contributions by the ILD and #Bonhanza_group. Stroopwafels were great, too. Thanks to #Jannik_Ruw, #Jakob_raith and Jan Gras for their talks and posters. #PRACTIS_MHH

[Intensive Care Medicine @yourICM]

Understanding dynamics of D-dimer during #ECMO support?? 🔥 Heated discussion happening on @youricm !!
🩸https://t.co/1dH9yUwvjY

Also read
🩸https://t.co/GmaU39ZGHz
🩸https://t.co/2iQSFmLFFG
🩸https://t.co/wEUzRJBAlt
Based on
🩸https://t.co/cjGejv8nWC
All #FOAMcc #FOAMecmo

[BonHanZA Study Group @Bonhanza_group]

Some impressions from our scientific contributions and social activities at #LIVES2023 conference in Milan. Thank you all, it was a pleasure! #esicm

[Jens GOTTLIEB ⭐ @GottliebJens]

Farewell to the best bronchoscopy assistant 👩‍⚕️↙️ of all time.

[Jonas Schupp @jonas_schupp]

Thanks also to the co-authors how don't appear on this short news!
@BenSeeliger @rsknipe @AurelienJustet @GottliebJens & not on Twitter Lavinia Neuber, Tobias Welte, Fabio Ius @BREATH_Hannover

[PRACTIS @PRACTIS_MHH]

Congratulations to our fellow @gerritgrosse for his vienna ligendi in "experimental neurology". #ClinicianScientist #MHH

[NEJM @NEJM]

In the STELLAR trial, a double-blind, randomized, placebo-controlled trial, sotatercept increased the exercise capacity of patients with pulmonary arterial hypertension. Full trial results: https://t.co/4vBD1CKL7a

#ACC23/#WCCardio

[BonHanZA Study Group @Bonhanza_group]

A great success for the BonHanZA team: @PeukertKonrad won the first prize for the best scientific talk at the #anesthesia conference #hai2022 and @christianbode10 won the Heinrich-Dräger-Prize for #intensivecaremedicine 2022. Congratulations to Konrad and Christian🎉!

[BonHanZA Study Group @Bonhanza_group]

Congratulations to our teammate @christianbode10 and his group on their #Nature paper revealing the link between metabolism and T cell function in #Covid_19 #ARDS 🎉
This project might pave the way for new treatment options in ARDS subphenotypes #PrecisionMedicine

[Wilhelm Lab @LabWilhelm]

Our latest study highlighting a link between infection-induced ketogenesis and T cell function @Nature Huge team effort @Fokaragiannis @PeukertKonrad @surace_laura @christianbode10 @PlacekKasia and many more https://t.co/x5BvNN3dTl

[BonHanZA Study Group @Bonhanza_group]

Thrilled to announce that @dfg_public will fund our multicenter study #EXCHANGE2 on therapeutic plasma exchange in septic shock🎉
👇🏻
https://t.co/viNHzg8aVv

[Chiara Robba @chiara_robba]

Our article is online on @yourICM https://t.co/oFyBy5KtbD

[The Lancet Respiratory Medicine @LancetRespirMed]

NEW Research—Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis

From Prof Marius Hoeper & colleagues https://t.co/iyf9AMvtom

[Sascha David @Sascha_David_]

Glad that this is finally out
After a tough review https://t.co/yhj6GvBd93

[Intensive Care Medicine @yourICM]

🩸On extracorporeal support #ECLS it takes 3 to bleed! Consider intersection of
1️⃣pt susceptibility
2️⃣management of anticoagulation/transfusions
3️⃣#ECMO circuit factors
📎 https://t.co/T5rq1BQ6l5
Authors' reply to
📎 https://t.co/tRLdC6BeeB
Referred to
📎 https://t.co/iU4vcO9171

[Intensive Care Medicine @yourICM]

How to challenge dogma if evidence non-existent, weak or outdated?
💦Loop diuretics needed to treat AHF
🩸Every #ICU pt should get heparin thromboprophylaxis
🧠Slow rate of Na+ correction prevents pontine myelinolysis
⌛️Each hour counts to treat meningitis
https://t.co/QUTTUqmg2B

[Intensive Care Medicine @yourICM]

Bleeding & thrombotic events on #ECMO, consider impact of:
🩸choice of/intensity of anticoagulation + monitoring
🩸pt-specific characteristics
Identifying & stratifying pts at risk will facilitate tailored approach
📎https://t.co/tRLdC6BeeB
In reply to
📎https://t.co/iU4vcO9171

[Dr. Glaucomflecken @DGlaucomflecken]

Nature does open access

[Ben Seeliger @BenSeeliger]

What is the right anticoagulation dose for COVID-19 on ECMO? Nobody's sure, but COVID was associated w/ 6x⬆️risk for intracranial hemorrhage. These were associated w/⬆️anticoagulation targets and 90% mortality.🇨🇭🇩🇪 @CritCareMed @PRACTIS_MHH #COVID19
https://t.co/TCYOQiUGu4

[Jens GOTTLIEB ⭐ @GottliebJens]

#lungtransplant or #ARDS in the pre-pandemic area. Results of 31 patients transplanted in 18 European centers. One year survival: 7⃣1⃣ %.
https://t.co/VIbBK25Tgv